STAT Summit By Andrew Joseph Chelsea Clinton wants Trump, allies to build support for a Covid-19 vaccine
STAT Summit By Elizabeth Cooney Bill Gates worries about a ‘dysfunctional’ approach to Covid-19 vaccine distribution
Health By Andrew Joseph Fauci suggests he should have been ‘much more vocal’ about Covid-19 testing early in pandemic
STAT Summit By Eric Boodman Hopeful Covid-19 vaccine data won’t help hospitals that are overstretched now, experts say
STAT Summit By STAT Staff Watch: VCs have to predict the future. Here’s what three of them expect next in biotech
In the Lab By STAT Staff Watch: Dr. James Wilson, a scientific pioneer, on the future of gene therapy
Politics By Nicholas Florko Moderate Democrats are still seeking changes to the party’s drug pricing package
STAT Summit By Megan Molteni Extending the reach of gene therapies means hurdling not just scientific barriers but prices, too
STAT Summit By Elizabeth Cooney ‘Aduhelm left room’: Lilly CEO eyes competition with Biogen Alzheimer’s drug
Health Tech By Elizabeth Cooney Measuring blood sugar in real time is a game changer for patients — and a health tech success story
STAT Summit By STAT Staff Watch: What patients and their families learned from facing a deadly disease
STAT Summit By STAT Staff A conversation with cancer researcher Charles Sawyers, winner of the first STAT Biomedical Innovation Award
STAT Summit By STAT Staff Watch: Top Biogen scientist explains why he’s confident in company’s drug for Alzheimer’s
Biotech By Nicholas Florko This invite-only club is grooming new biotech CEOs — and helping make them less lonely, too
Politics By Nicholas Florko Our drug policy often prioritizes eliminating rare disease. One researcher asks: Is that the right goal?
The Readout LOUD By Damian Garde, Rebecca Robbins and Adam Feuerstein Listen: Warren’s awkward home front, the ethics of treating dwarfism, and the sound of STAT Summit
Pharmalot By Ed Silverman Having gobbled up Celgene, the Bristol-Myers CEO ducks questions about his key rival
STAT Summit By Casey Ross A bold prediction: Machine learning will yield new drug candidates within three years
Biotech By Kate Sheridan ‘The industry has earned it’: Three CEOs own up to biopharma’s bad reputation
In the Lab By Rebecca Robbins Gene therapy pioneer says the field is behind — and that delivery technology is ‘embarrassing’
Health By Shraddha Chakradhar Longtime cancer researcher Charles Sawyers named first STAT Biomedical Innovation Award winner